← All devices 
Continuous cuffless BP (SaMD) · Garment · by Nanowear
Nanowear SimpleSense-BP
A nanotech-woven undergarment that continuously tracks blood pressure and 85+ cardiopulmonary biomarkers — FDA-cleared software-as-a-medical-device.
2023SimpleSense-BP (FDA SaMD)
Maturing3 yr 1 mo old
API access: Yes — restricted Raw data access: Yes — restricted Open source: No public repo
Clinical value
70/100
FDA SaMD, continuous BP
Empowerment
40/100
Clinical pipeline
Everyday value
30/100
Garment, clinical use
A nanotechnology-woven garment that continuously tracks blood pressure and 85+ cardiopulmonary biomarkers with AI, FDA-cleared as software-as-a-medical-device and validated to track systolic changes of ±15 mmHg across hypertension classes.
What it measures
Continuous cuffless blood pressure and 85+ cardiopulmonary biomarkers from a woven-nanosensor garment, with AI-enabled hemodynamic assessment.
Regulatory status
FDA 510(k) SaMD; validated for continuous BP tracking across hypertension classes.
Validation & accuracy
Validated to track ±15 mmHg systolic changes continuously across all hypertension classes — a clinical-grade capability.
Data control & export
Raw data: restricted — flows through clinical/RPM pipelines rather than a consumer export.
Wearability & battery
A woven garment worn against the skin for monitoring; clinical/RPM oriented rather than all-day lifestyle wear.
Cost & access
Clinical/enterprise channel pricing.
Who it serves
Clinicians and hypertension/cardiopulmonary patients needing continuous, cleared BP and hemodynamics.
Who is left out or burdened
Garment form; clinical channel; data not consumer-portable.
✓ Strengths
- FDA SaMD continuous cuffless BP
- 85+ cardiopulmonary biomarkers
- Validated across hypertension classes
- AI hemodynamic assessment
✕ Weaknesses
- Clinical/RPM channel only
- Garment form factor
- No consumer data export
- Not lifestyle wear
70
Why this clinical score. FDA SaMD clearance for continuous cuffless BP across hypertension classes makes it clinically strong.
40
Why this empowerment score. Data lives in clinical/RPM pipelines with no consumer export, holding empowerment mid-low.
30
Why this everyday score. A monitoring garment for clinical use offers limited everyday consumer value.
Reviews & coverage
Coverage highlights Nanowear’s nanosensor garment as an FDA-cleared route to continuous cuffless blood pressure and dense cardiopulmonary biomarkers. It is framed as a clinical/RPM platform, not a consumer device, with data confined to clinical pipelines.
Summary is a draft synthesis of public coverage, not an endorsement. Links open a search of each outlet.
Reddit communities
Independent user communities where this device (or its category) is discussed.
Get it · manuals & support
Draft profile · public-source review, June 2026 · scores describe direction and degree, not buying advice. News, links, and prices change — verify with the manufacturer. Image is representative.